$GYHT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HALOZYME THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HALOZYME THERAPEUTICS, INC.. Get notifications about new insider transactions in HALOZYME THERAPEUTICS, INC. for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 15 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.98 | 1,900 | 17,062 | 80,522 | 82.4 K to 80.5 K (-2.31 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.97 | 100 | 897 | 82,422 | 82.5 K to 82.4 K (-0.12 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.96 | 265 | 2,374 | 82,522 | 82.8 K to 82.5 K (-0.32 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.95 | 1,184 | 10,597 | 82,787 | 84 K to 82.8 K (-1.41 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.94 | 900 | 8,046 | 83,971 | 84.9 K to 84 K (-1.06 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.93 | 700 | 6,251 | 84,871 | 85.6 K to 84.9 K (-0.82 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.92 | 500 | 4,460 | 85,571 | 86.1 K to 85.6 K (-0.58 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.91 | 200 | 1,782 | 86,071 | 86.3 K to 86.1 K (-0.23 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.90 | 1,200 | 10,680 | 86,271 | 87.5 K to 86.3 K (-1.37 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.89 | 200 | 1,778 | 87,471 | 87.7 K to 87.5 K (-0.23 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.88 | 400 | 3,552 | 87,671 | 88.1 K to 87.7 K (-0.45 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.87 | 200 | 1,774 | 88,071 | 88.3 K to 88.1 K (-0.23 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.86 | 500 | 4,430 | 88,271 | 88.8 K to 88.3 K (-0.56 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.85 | 348 | 3,080 | 88,771 | 89.1 K to 88.8 K (-0.39 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.84 | 800 | 7,072 | 89,119 | 89.9 K to 89.1 K (-0.89 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.83 | 708 | 6,252 | 89,919 | 90.6 K to 89.9 K (-0.78 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.82 | 100 | 882 | 90,627 | 90.7 K to 90.6 K (-0.11 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.81 | 652 | 5,744 | 90,727 | 91.4 K to 90.7 K (-0.71 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.80 | 92 | 810 | 91,379 | 91.5 K to 91.4 K (-0.10 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.78 | 200 | 1,756 | 91,471 | 91.7 K to 91.5 K (-0.22 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.77 | 200 | 1,754 | 91,671 | 91.9 K to 91.7 K (-0.22 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.76 | 100 | 876 | 91,871 | 92 K to 91.9 K (-0.11 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.75 | 400 | 3,500 | 91,971 | 92.4 K to 92 K (-0.43 %) |
| Sep 19 2007 | GYHT | HALOZYME THERAPEUT ... | PATTON JOHN STUART | Director | Sell | S | 8.70 | 100 | 870 | 92,371 | 92.5 K to 92.4 K (-0.11 %) |
| Sep 17 2007 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | P | 8.66 | 238,020 | 2,061,253 | 3,931,426 | 3.7 M to 3.9 M (+6.44 %) |
| Sep 17 2007 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | P | 8.71 | 127,693 | 1,112,206 | 3,693,406 | 3.6 M to 3.7 M (+3.58 %) |
| Sep 17 2007 | GYHT | HALOZYME THERAPEUT ... | KIRK RANDAL J | Director | Buy | P | 8.74 | 65,713 | 574,332 | 3,565,713 | 3.5 M to 3.6 M (+1.88 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.96 | 100 | 896 | 673,310 | 673.4 K to 673.3 K (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.95 | 400 | 3,580 | 673,410 | 673.8 K to 673.4 K (-0.06 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.94 | 584 | 5,221 | 673,810 | 674.4 K to 673.8 K (-0.09 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.93 | 516 | 4,608 | 674,394 | 674.9 K to 674.4 K (-0.08 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.92 | 200 | 1,784 | 674,910 | 675.1 K to 674.9 K (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.91 | 400 | 3,564 | 675,110 | 675.5 K to 675.1 K (-0.06 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.90 | 1,200 | 10,680 | 675,510 | 676.7 K to 675.5 K (-0.18 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.89 | 200 | 1,778 | 676,710 | 676.9 K to 676.7 K (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.88 | 100 | 888 | 676,910 | 677 K to 676.9 K (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.87 | 400 | 3,548 | 677,010 | 677.4 K to 677 K (-0.06 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.86 | 200 | 1,772 | 677,410 | 677.6 K to 677.4 K (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.85 | 800 | 7,080 | 677,610 | 678.4 K to 677.6 K (-0.12 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.84 | 1,000 | 8,840 | 678,410 | 679.4 K to 678.4 K (-0.15 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.83 | 1,000 | 8,830 | 679,410 | 680.4 K to 679.4 K (-0.15 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.82 | 200 | 1,764 | 680,410 | 680.6 K to 680.4 K (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.81 | 100 | 881 | 680,610 | 680.7 K to 680.6 K (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.80 | 200 | 1,760 | 680,710 | 680.9 K to 680.7 K (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.79 | 400 | 3,516 | 680,910 | 681.3 K to 680.9 K (-0.06 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.77 | 100 | 877 | 681,310 | 681.4 K to 681.3 K (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.76 | 100 | 876 | 681,410 | 681.5 K to 681.4 K (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.75 | 800 | 7,000 | 681,510 | 682.3 K to 681.5 K (-0.12 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.74 | 200 | 1,748 | 682,310 | 682.5 K to 682.3 K (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.73 | 100 | 873 | 682,510 | 682.6 K to 682.5 K (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.72 | 1,000 | 8,720 | 682,610 | 683.6 K to 682.6 K (-0.15 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.71 | 600 | 5,226 | 683,610 | 684.2 K to 683.6 K (-0.09 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.70 | 1,900 | 16,530 | 684,210 | 686.1 K to 684.2 K (-0.28 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Option Exercise | M | 0.39 | 25,000 | 9,750 | 2,279,003 | |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.69 | 1,600 | 13,904 | 686,110 | 687.7 K to 686.1 K (-0.23 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.68 | 700 | 6,076 | 687,710 | 688.4 K to 687.7 K (-0.10 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.67 | 300 | 2,601 | 688,410 | 688.7 K to 688.4 K (-0.04 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.66 | 200 | 1,732 | 688,710 | 688.9 K to 688.7 K (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.64 | 300 | 2,592 | 688,910 | 689.2 K to 688.9 K (-0.04 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.63 | 400 | 3,452 | 689,210 | 689.6 K to 689.2 K (-0.06 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.62 | 1,400 | 12,068 | 689,610 | 691 K to 689.6 K (-0.20 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.61 | 100 | 861 | 691,010 | 691.1 K to 691 K (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.60 | 500 | 4,300 | 691,110 | 691.6 K to 691.1 K (-0.07 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.59 | 1,100 | 9,449 | 691,610 | 692.7 K to 691.6 K (-0.16 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.58 | 220 | 1,888 | 692,710 | 692.9 K to 692.7 K (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.57 | 220 | 1,885 | 692,930 | 693.2 K to 692.9 K (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.56 | 100 | 856 | 693,150 | 693.3 K to 693.2 K (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.55 | 200 | 1,710 | 693,250 | 693.5 K to 693.3 K (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.54 | 700 | 5,978 | 693,450 | 694.2 K to 693.5 K (-0.10 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.53 | 580 | 4,947 | 694,150 | 694.7 K to 694.2 K (-0.08 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.52 | 80 | 682 | 694,730 | 694.8 K to 694.7 K (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.51 | 100 | 851 | 694,810 | 694.9 K to 694.8 K (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.50 | 1,025 | 8,713 | 694,910 | 695.9 K to 694.9 K (-0.15 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.49 | 100 | 849 | 695,935 | 696 K to 695.9 K (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.48 | 600 | 5,088 | 696,035 | 696.6 K to 696 K (-0.09 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.47 | 260 | 2,202 | 696,635 | 696.9 K to 696.6 K (-0.04 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.46 | 40 | 338 | 696,895 | 696.9 K to 696.9 K (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.42 | 200 | 1,684 | 696,935 | 697.1 K to 696.9 K (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.40 | 200 | 1,680 | 697,135 | 697.3 K to 697.1 K (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.35 | 400 | 3,340 | 697,335 | 697.7 K to 697.3 K (-0.06 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.34 | 200 | 1,668 | 697,735 | 697.9 K to 697.7 K (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.31 | 105 | 873 | 697,935 | 698 K to 697.9 K (-0.02 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Sell | S | 8.30 | 270 | 2,241 | 698,040 | 698.3 K to 698 K (-0.04 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Lim Jonathan E | President, CEO | Buy | M | 0.39 | 25,000 | 9,750 | 698,310 | 673.3 K to 698.3 K (+3.71 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,815 | 6,800 | 930,560 | |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.59 | 100 | 859 | 3,019,606 | 3 M to 3 M (0.00 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.58 | 200 | 1,716 | 3,019,706 | 3 M to 3 M (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.57 | 479 | 4,105 | 3,019,906 | 3 M to 3 M (-0.02 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.54 | 100 | 854 | 3,020,385 | 3 M to 3 M (0.00 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.53 | 100 | 853 | 3,020,485 | 3 M to 3 M (0.00 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.51 | 100 | 851 | 3,020,585 | 3 M to 3 M (0.00 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.50 | 1,600 | 13,600 | 3,020,685 | 3 M to 3 M (-0.05 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.49 | 2,800 | 23,772 | 3,022,285 | 3 M to 3 M (-0.09 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.48 | 800 | 6,784 | 3,025,085 | 3 M to 3 M (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.47 | 300 | 2,541 | 3,025,885 | 3 M to 3 M (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.46 | 1,321 | 11,176 | 3,026,185 | 3 M to 3 M (-0.04 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.45 | 500 | 4,225 | 3,027,506 | 3 M to 3 M (-0.02 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.44 | 100 | 844 | 3,028,006 | 3 M to 3 M (0.00 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.43 | 710 | 5,985 | 3,028,106 | 3 M to 3 M (-0.02 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.42 | 990 | 8,336 | 3,028,816 | 3 M to 3 M (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.41 | 675 | 5,677 | 3,029,806 | 3 M to 3 M (-0.02 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.40 | 1,325 | 11,130 | 3,030,481 | 3 M to 3 M (-0.04 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.39 | 200 | 1,678 | 3,031,806 | 3 M to 3 M (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.38 | 1,200 | 10,056 | 3,032,006 | 3 M to 3 M (-0.04 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.37 | 900 | 7,533 | 3,033,206 | 3 M to 3 M (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.36 | 300 | 2,508 | 3,034,106 | 3 M to 3 M (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.35 | 100 | 835 | 3,034,406 | 3 M to 3 M (0.00 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.34 | 100 | 834 | 3,034,506 | 3 M to 3 M (0.00 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 8.34 | 815 | 6,797 | 3,034,606 | 3 M to 3 M (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,815 | 6,800 | 3,035,421 | 3 M to 3 M (+0.52 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,801 | 6,794 | 946,375 | |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.45 | 100 | 845 | 3,019,606 | 3 M to 3 M (0.00 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.44 | 500 | 4,220 | 3,019,706 | 3 M to 3 M (-0.02 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.43 | 100 | 843 | 3,020,206 | 3 M to 3 M (0.00 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.42 | 900 | 7,578 | 3,020,306 | 3 M to 3 M (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.41 | 600 | 5,046 | 3,021,206 | 3 M to 3 M (-0.02 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.40 | 100 | 840 | 3,021,806 | 3 M to 3 M (0.00 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.39 | 100 | 839 | 3,021,906 | 3 M to 3 M (0.00 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.38 | 600 | 5,028 | 3,022,006 | 3 M to 3 M (-0.02 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.37 | 100 | 837 | 3,022,606 | 3 M to 3 M (0.00 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.36 | 28 | 234 | 3,022,706 | 3 M to 3 M (0.00 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.35 | 772 | 6,446 | 3,022,734 | 3 M to 3 M (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.31 | 1,300 | 10,803 | 3,023,506 | 3 M to 3 M (-0.04 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.29 | 700 | 5,803 | 3,024,806 | 3 M to 3 M (-0.02 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.28 | 700 | 5,796 | 3,025,506 | 3 M to 3 M (-0.02 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.27 | 500 | 4,135 | 3,026,206 | 3 M to 3 M (-0.02 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.26 | 200 | 1,652 | 3,026,706 | 3 M to 3 M (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.25 | 1,100 | 9,075 | 3,026,906 | 3 M to 3 M (-0.04 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.24 | 800 | 6,592 | 3,028,006 | 3 M to 3 M (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.23 | 1,000 | 8,230 | 3,028,806 | 3 M to 3 M (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.22 | 900 | 7,398 | 3,029,806 | 3 M to 3 M (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.21 | 700 | 5,747 | 3,030,706 | 3 M to 3 M (-0.02 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.20 | 1,400 | 11,480 | 3,031,406 | 3 M to 3 M (-0.05 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.19 | 700 | 5,733 | 3,032,806 | 3 M to 3 M (-0.02 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.18 | 300 | 2,454 | 3,033,506 | 3 M to 3 M (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.17 | 300 | 2,451 | 3,033,806 | 3 M to 3 M (-0.01 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 8.16 | 500 | 4,080 | 3,034,106 | 3 M to 3 M (-0.02 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 8.48 | 801 | 6,792 | 3,034,606 | 3 M to 3 M (-0.03 %) |
| Aug 31 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,801 | 6,794 | 3,035,407 | 3 M to 3 M (+0.52 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,816 | 6,801 | 1,014,943 | |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Option Exercise | M | 0.43 | 15,850 | 6,816 | 1,030,759 | |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.99 | 1,301 | 10,395 | 2,980,906 | 3 M to 3 M (-0.04 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.98 | 600 | 4,788 | 2,982,207 | 3 M to 3 M (-0.02 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.96 | 400 | 3,184 | 2,982,807 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.95 | 400 | 3,180 | 2,983,207 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.94 | 200 | 1,588 | 2,983,607 | 3 M to 3 M (-0.01 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.93 | 700 | 5,551 | 2,983,807 | 3 M to 3 M (-0.02 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Sell | S | 7.89 | 99 | 781 | 2,984,507 | 3 M to 3 M (0.00 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Payment of Exercise | F | 8.33 | 816 | 6,797 | 2,984,606 | 3 M to 3 M (-0.03 %) |
| Aug 03 2007 | GYHT | HALOZYME THERAPEUT ... | Frost Gregory Ian | VP and Chief Scient ... | Buy | M | 0.43 | 15,816 | 6,801 | 2,985,422 | 3 M to 3 M (+0.53 %) |